Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Indo-Rama Synthetics Tbk. (INDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Indo-Rama Synthetics Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Indo-Rama Synthetics Tbk. trades at Rp2,030 (market cap 1.33T). The key difference: Indo-Rama Synthetics Tbk. is far larger — about 4.3× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| DGNS | INDR | |
|---|---|---|
Market Cap | 308B | 1.33T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Indo-Rama Synthetics Tbk.
PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.
Read more on INDR →
